DR. DAMANJIT GHUMAN MD
NPI 1649366832
Internal Medicine - Medical Oncology in Jersey City, NJ

Active since October 05, 2006PECOS EnrolledAccepts Medicare Assignment
100/100
CMS Quality Rating
2 JOURNAL SQ PLAZA, 2ND FLOOR, JERSEY CITY, NJ 07306(201) 963-7000 Get Directions Write a Review

NPPES record last updated: June 24, 2025. Verified against the NPPES registry weekly; last sync: August 16, 2026.

About Dr. Damanjit Ghuman Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. DAMANJIT GHUMAN MD (NPI 1649366832) is an individual medical oncology provider in Jersey City, New Jersey, licensed in New Jersey (25MA07635300) and active in the NPI registry since October 2006. She is enrolled in Medicare PECOS, is affiliated with Englewood Hospital And Medical Center, and is a graduate of Other (2000).

NPPES Registry Identity

NPI1649366832
Entity TypeIndividualFemale
Primary Taxonomy207RX0202X
Provider Legal NameDR. DAMANJIT GHUMANCredential: MD
Location Address2 JOURNAL SQ PLAZA, 2ND FLOORJersey City, NJ 07306
Mailing Address2 Journal Sq Plaza, 2nd FloorJersey City, NJ 07306 · (201) 963-7000
Sole ProprietorNo
Medical School CMSOtherGraduated 2000
Enumeration DateOctober 5, 2006
Last NPPES UpdateJune 24, 2025
NPPES CertifiedJune 24, 2025
NPI 1649366832 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyInternal Medicine · Medical OncologyAllopathic & Osteopathic Physicians
Taxonomy Code207RX0202X
License Licensed in NJ · 25MA07635300
Definition
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
2 JOURNAL SQ PLAZA, Jersey City, NJ 07306

Other Identifiers 1

Medicaid0102156NJ

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Damanjit Ghuman Md is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID1254434251
PECOS Enrollment IDI20070313000088
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 31

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Injection, romosozumab-aqqg, 1 mg J3111
Romosozumab-aqqg is a medication given by injection to treat osteoporosis in patients at high risk for fractures. It works by increasing bone mass and strength, reducing the risk of fractures.
42,945 services69 patients
Injection, denosumab, 1 mg J0897
Denosumab is a medication given via injection to strengthen your bones. It works by slowing down the cells that break down bone, improving bone density and reducing the risk of fractures. It's often used for osteoporosis treatment.
29,760 services432 patients
Injection, iron sucrose, 1 mg J1756
Iron sucrose injection is a treatment given to replenish iron in your body, often used when oral iron supplements are not effective. This helps your body make red blood cells, improving health and energy levels.
9,400 services29 patients
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Q0138
Ferumoxytol injection is a treatment for iron deficiency anemia, a condition where your body lacks enough iron. It is injected into your vein to increase iron levels, aiding in the production of healthy red blood cells. This treatment is not for ESRD patients.
7,140 services13 patients
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg J1561
This is an injection of immune globulin, specifically Gamunex-C or Gammaked. It's a liquid form, not freeze-dried. Immune globulin is a blood product that helps your immune system to fight infections. It's given in a dose of 500 mg.
6,210 services20 patients
Injection, dexamethasone sodium phosphate, 1 mg J1100
Dexamethasone sodium phosphate is a medication given via injection. It is a type of steroid that helps reduce inflammation and immune responses. It can be used to treat a variety of conditions, such as allergies, skin conditions, arthritis, and more.
1,287 services29 patients

Hospital Affiliations CMS Care Compare

Hospitals where this provider delivers care, identified from recent Medicare claims and place-of-service records.

Englewood Hospital And Medical Center

Acute Care Hospitals · Englewood, NJ
4/5 CMS rating
OwnershipVoluntary non-profit - Private
CMS Certification Number310045
Location350 Engle StEnglewood, NJ 07631 · Bergen County
Emergency services Birthing friendly

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 07306 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$190.92 typical visit price
range $63.84 – $190.92
Typical copayment $47.73 (range $15.96 – $47.73)
Most-billed visit code 99205
Established Patient
$111.57 typical visit price
range $20.97 – $155.92
Typical copayment $27.89 (range $5.24 – $38.98)
Most-billed visit code 99214
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

100/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Promoting Interoperability100
Improvement Activities40

Reported Quality Measures

Breast Cancer Screening
Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer
98%316 patients5/55-star benchmark: 92%
Care Plan
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker…
100%362 patients5/55-star benchmark: 100%
Colorectal Cancer Screening
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer
99%472 patients5/55-star benchmark: 85%
Documentation of Current Medications in the Medical Record
Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
97%4,782 patients4/55-star benchmark: 100%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
98%456 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Pain Intensity Quantified
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified
94%1,209 patients4/55-star benchmark: 100%
Oncology: Medical and Radiation - Plan of Care for Pain
Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain
92%548 patients4/55-star benchmark: 100%
Pain Assessment and Follow-Up
Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present
90%4,782 patients4/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
98%1,086 patients4/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
92%364 patients5/55-star benchmark: 90%
Preventive Care and Screening: Influenza Immunization
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
44%1,102 patients3/55-star benchmark: 88%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
86%87 patients4/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
71%1,086 patients3/55-star benchmark: 100%
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
22%1,086 patients2/55-star benchmark: 79%
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Referred Medical Equipment & Supplies CMS DME claims

Durable medical equipment, devices and supplies this provider ordered from DME suppliers for patients, from Medicare fee-for-service claims.

Capecitabine, oral, 500 mg J8521
Treatment-Treatment - Miscellaneous · category RX029N
2 suppliers17 claims952 services$0.75 avg. paid by Medicare
Dollar amounts are the average Medicare paid the supplier per service. They are not the cost to the patient.

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Damanjit Ghuman's NPI number?

The NPI number for Damanjit Ghuman is 1649366832. It was assigned to this individual provider in the NPPES registry on October 5, 2006.

Where is Damanjit Ghuman located?

Damanjit Ghuman practices at 2 Journal Sq Plaza 2nd Floor, Jersey City, NJ 07306. The listed phone number is (201) 963-7000.

What is Damanjit Ghuman's specialty?

The primary specialty registered for this NPI is Internal Medicine, specializing in Medical Oncology, with taxonomy code 207RX0202X.

Is Damanjit Ghuman enrolled in Medicare?

Yes. Damanjit Ghuman is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

Is Damanjit Ghuman affiliated with any hospitals?

According to CMS data, Damanjit Ghuman is affiliated with Englewood Hospital And Medical Center.

When was this NPI record last updated?

The NPPES record for Damanjit Ghuman was last updated on June 24, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 13 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.